Diagnostic and predictive capabilities of the method for the quantification of C-reactive protein in patients with community-acquired pneumonia


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription Access

Abstract

According to numerous researches the authors emphasize the importance of the quantification of C-reactive protein in patients with community-acquired pneumonia. We gave an analysis of different publications on the given issue. We came to conclusion that available laboratory kits for the quantification of C-reactive protein in blood serum, including instant diagnosis, allow considering the given method as a method of common use for military-medical facilities.

Full Text

Restricted Access

References

  1. Авдеев С.Н., Баймаканова Г.Е., Зубаирова П.А. Возможности С-реактивного белка в диагностике бактериальной инфекции и пневмонии у больных с обострением хронической обструктивной болезни легких // Уральский мед. журн. — 2008. — № 13. — С. 19-24.
  2. Agapakis D.I., Tsantilas D., Pramis P. et al. Coagulation and inflammation biomarkers may help predict the severity of community-acquired pneumonia // Respir. — 2010. — Vol. 15(5). — P. 796—803.
  3. Almirall J., Bolipar I., Vidal J. et al. Contribution of C-reactive protein to the diagnosis and assessment of severity of community-acquired pneumonia // Chest. — 2004. — Vol. 125. — P. 1335— 1342.
  4. Bafadhel M., Clark T.W., Reid C. et al. Procalcitonin and Creactive protein in hospitalized adult patients with communityacquired pneumonia or exacerbation of asthma or COPD // Chest. — 2011. — 139 (6). — P. 1410—1418.
  5. Bauer S., Lamy O. Role of C-reactive protein in the diagnosis, prognosis and follow-up of community-acquired pneumonia // Rev. Med. Suisse. — 2010. — Vol. 6(269). — P. 2068—2070, 2072— 2073.
  6. Bruns A.H., Oosterheert J.J., Hak E., Hoepelman A.I. Usefulness of consecutive C-reactive protein measurements in follow-up of severe community-acquired pneumonia // Eur. Respir. J. — 2008. — Vol. 32. — P. 726—732.
  7. Castro-Guardiola A., Armengou-Arxe A., Viedjo-Rodriguez A. et al. Differential diagnosis between community-acquired pneumonia and non-pneumonia diseases of the chest in the emergency ward // Eur. J. Intern. Med. — 2000. — Vol. 11. — P. 334—339.
  8. Chalmers J., Singanayagam A., Hill A. C-reactive protein is an independent predictor of severity in community-acquired pneumonia // Am. J. Med. — 2008. — Vol. 121. — P. 219—225.
  9. Coelho L., Povoa P., Almeida E. et al. Usefulness of C-reactive protein in monitoring the severe community-acquired pneumonia clinical course // Crit. Care. — 2007. — Vol. 11(4). — P. 92.
  10. Espana P.P., Capelastegui A., Bilbao A. et al. Population Study of Pneumonia (PSoP) Group. Utility of two biomarkers for directing care among patients with non-severe community-acquired pneumonia // Eur. J. Clin. Microbiol. Infect. Dis. — 2012. — Vol. 31(12). — P. 3397—3405.
  11. Flanders S.A., Stein J., Shochat G. et al. Performance of a bedside C-reactive protein test in the diagnosis of community-acquired pneumonia in adults with acute cough // Amer. J. Med. — 2004. — Vol. 116. — P. 529—535.
  12. Garcia Vazquez E., Martines J.A., Menza J. et al. C-reactive protein levels in community-acquired pneumonia // Eur. Respir. J. — 2003. — Vol. 21. — P. 702—705.
  13. Hirschfield G.M., Pepys M.B. C-reactive protein and cardiovascular disease: new insights from an old molecule // Q. J. Med. — 2003. — Vol. 96(11). — P. 793—807.
  14. Hohenthal U., Hurme S., Helenius H. et al. Utility of C-reactive protein in assessing the disease severity and complications of community-acquired pneumonia // Clin. Microbiol. Infect. — 2009. — Vol. 15(11). — P. 1026—1032.
  15. Korppi M., Heiskanen-Kosma T., Leininen M. White blood cells, C-reactive protein and erythrocyte sedimentation rate in pneumococcal pneumonia in children // Eur. Respir. J. — 1997. — Vol. 10. — P. 1125—1129.
  16. Krüger S., Ewig S., Papassotiriou J. et al. CAPNETZ Study Group. Inflammatory parameters predict etiologic patterns but do not allow for individual prediction of etiology in patients with CAP: results from the German competence network CAPNETZ // Respir. Res. — 2009. — Vol. 10 (1). — P. 65.
  17. Lehtomaki K. Clinical diagnosis of pneumococcal, adenoviral, mycoplasmal and mixed pneumonias in young men // Eur. Respir. J. — 1988. — Vol. 1. — P. 324—329.
  18. Lobo S.M., Lobo F.R., Bota D.P. et al. C-reactive protein levels correlate with mortality and organ failure in critically ill patients // Chest. — 2003. — Vol. 123. — P. 2043—2049.
  19. Macfarlane J., Holmes W., Gard P. et al. Prospective study of the incidence, aetiology and outcome of adult lower respiratory tract illness in the community // Thorax. — 2001. — Vol. 56. — P. 109—114.
  20. MacLeod C.M., Avery O.T. The occurrence during acute infections of a protein not normally present in the blood : II. Isolation and properties of the reactive protein // J. Exp. Med. — 1941. — Vol. 73(2). — P. 183—190.
  21. McCarthy P.L., Frank A.L., Ablou R.C. et al. Value of the C-reactive protein test in the differentiation of bacterial and viral pneumonia // J. Pediatr. — 1978. — Vol. 92. — P. 454—456.
  22. Pepys M.B., Hirschfield G.M. C-reactive protein: a critical update // J. Clin. Invest. — 2003. — Vol. 111. — P. 1805—1812.
  23. Ruiz-Gonzcilez A., Falguera M., Porcel J.M. et al. C-reactive protein for discriminating treatment failure from slow responding pneumonia // Eur. J. Int. Med. — 2010. — Vol. 21. — P. 548—552.
  24. Shine B., de Beer F.C., Pepis M.B. et al. Solid phase radioimmunoassays for human C-reactive protein // Clin. Chim. Acta. — 1981. — Vol. 117. — P. 13—23.
  25. Smith R.P. C-reactive protein in simple community-acquired pneumonia // Chest. — 1995. — Vol. 107. — P. 1028—1031.
  26. Tillet W., Francis T. Serological reaction in pneumonia with a non-protein somatic fraction of Pneumococcus // J. Exp. Med. — 1930. — Vol. 52. — P. 561—571.
  27. Van der Meer V., Neven A., Van den Broek P., Assendelft W. Diagnostic value of C reactive protein in infections of the lower respiratory tract: systematic review // BMJ. — 2005. — Vol. 331 (7507). — P. 26.
  28. Young Ae Kang, Sung-Youn Kwon, Ho IL Yoon et al. Role of C-Reactive Protein and Procalcitonin in Differentiation of Tuberculosis from Bacterial Community Acquired Pneumonia // Korean J. Intern. Med. — 2009. — Vol. 24(4). — P. 337—342.
  29. Young B., Greeson M., Gripps A.W. et al. C-reactive protein: a critical review // Pathology. — 1991. — Vol. 23. — P. 118—124.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2013 Zaytsev A.A., Kondratyeva T.V., Madzhanova E.R.


СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: № 01975 от 30.12.1992.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies